Actuality. One of the significant ophthalmic diseases is a dry form age-related macular degeneration (dAMD). The issues of etiology and pathogenesis are not completely cleared nowadays and they signify the subject of discussion. There are risk factors of
A. A. Volozhev +5 more
doaj +1 more source
Current and emerging therapies for dry and neovascular age-related macular degeneration
Age-related macular degeneration (AMD), first identified in the 1840s, is now considered the leading cause of visual impairment in elderly people in Western societies. This condition affects the macula, a region rich with photoreceptors essential for detailed visual resolution and colour vision.
Ghayth M. Abdulrazzaq +7 more
openaire +3 more sources
Foreword: Dry Age-Related Macular Degeneration
Milam A, Brantley, James T, Handa
openaire +2 more sources
New developments in age-related macular degeneration
The World Health Organization (WHO) estimates that over 3 million people (9% of global blindness) are blinded by age-related macular degeneration (AMD). AMD affects people over the age of 55. There are two main types of AMD, dry and wet.
Lyndon da Cruz
doaj
Single-cell and spatial analyses reveal endothelial-macrophage inflammatory crosstalk in dry age-related macular degeneration. [PDF]
Chen Y +9 more
europepmc +1 more source
Functional and Structural Outcomes of Photobiomodulation Therapy in Dry Age-Related Macular Degeneration: A Single-Center Experience. [PDF]
Ipek SC +4 more
europepmc +1 more source
Circulating Claudin-5 and Systemic Inflammatory Indices in Wet and Dry Age-Related Macular Degeneration. [PDF]
Çatak O, Keleş JK, Çatak Z.
europepmc +1 more source
A human amelotin transgenic mouse model with calcified deposits similar to those in dry age-related macular degeneration. [PDF]
Rajapakse D +6 more
europepmc +1 more source
The Effect of Nutrition on Dry Age-Related Macular Degeneration: A Systematic Narrative Review of Evidence and Clinical Implications. [PDF]
Istanaksai A +5 more
europepmc +1 more source

